Alivus Life Sciences Ltd.

BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
900.20
10.60 (1.19%)
< Home < Back

CCI gives green signal for Nirma’s acquisition in Glenmark Life Sciences

Date: 20-12-2023

The Competition Commission of India (CCI) has given approval for Nirma’s acquisition of majority shareholding in Glenmark Life Sciences. In September this year, Glenmark Pharmaceuticals’ board had approved to divest 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma for Rs 5,651.5 crore.

Ahmedabad-based Nirma is known for its detergents, soap, and dishwashing bars. It is also into the manufacturing of industrial products like soda ash, linear alkyl benzene, alfa olefin sulphonates, fatty acid, glycerine, and sulphuric acid. 

Glenmark Life Sciences is in the business of making high-quality drugs by unlocking the possibilities of science.